Camargo Pharmaceutical Services

Feb 08, 2021

Hoth Therapeutics Partners with Camargo Pharmaceutical Services for the HT-001 IND, a Treatment for Cancer Patients

Dec 01, 2020

Camargo client Incannex Healthcare seeks expedited pre-IND meeting, Emergency Use Authorization for anti-inflammatory COVID-19 treatment

Oct 13, 2020

Jennie Orr Appointed Chief Strategy and Business Officer at Camargo Pharmaceutical Services, LLC

Jul 02, 2020

Camargo client Chiasma receives FDA approval for first and only oral somatostatin analog for long-term maintenance treatment of acromegaly